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Abstract
Tackling protein interfaces with small molecules capable of modulating protein-protein inter-
actions remains a challenge in structure-based ligand design. Particularly arduous are
cases in which the epitopes involved in molecular recognition have a non-structured and
discontinuous nature. Here, the basic strategy of translating continuous binding epitopes
into mimetic scaffolds cannot be applied, and other innovative approaches are therefore
required. We present a structure-based rational approach involving the use of a regular
expression syntax inspired in the well established PROSITE to define minimal descriptors
of geometric and functional constraints signifying relevant functionalities for recognition in
protein interfaces of non-continuous and unstructured nature. These descriptors feed a
search engine that explores the currently available three-dimensional chemical space of the
Protein Data Bank (PDB) in order to identify in a straightforward manner regular architec-
tures containing the desired functionalities, which could be used as templates to guide the
rational design of small natural-like scaffolds mimicking the targeted recognition site. The
application of this rescaffolding strategy to the discovery of natural scaffolds incorporating a
selection of functionalities of interleukin-10 receptor-1 (IL-10R1), which are relevant for its
interaction with interleukin-10 (IL-10) has resulted in the de novo design of a new class of
potent IL-10 peptidomimetic ligands.
Introduction
Protein-protein interactions (PPIs) mediate most biological processes and, therefore, represent
relevant avenues as targets for the development of therapeutics. In order to target large pro-
tein-protein interfaces with small molecules in a rational fashion, the most relevant molecular
interactions in the functional ligand-receptor complex need to be identified and mimicked
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appropriately. The rational design of molecules that disrupt PPIs is particularly challenging
due to the large and structurally complex nature of the interfaces involved. A decisive strategy
has been the identification of key binding residues, which contribute to the majority of stabiliz-
ing interactions [1–6]. In some cases, the most contributing residues at the binding interface
appear organized in a continuous and well-defined manner in regular architectures (i.e. sec-
ondary structures: α-helices, β-strands and turns). In these cases, the binding epitope contain-
ing such key binding residues can be directly translated into a chemical scaffold consisting of
the same structural features (for instance, mimetics of protein α-helices, β-hairpins or turns)
[7–11]. However, in most cases, the large size, the discontinuous nature, and even the lack of
well-defined secondary structure of protein-protein interfaces [12–14] do not allow a straight-
forward transfer of such relevant residues directly into a small scaffold with high affinity to the
targeted recognition site [2, 4]. Antibody-based strategies have been widely exploited for inter-
fering large and structurally complex protein interfaces [15, 16]. Nevertheless, antibodies are
suboptimal as drugs mainly due to their low oral bioavailability and cell permeability, slow
pharmacokinetics and, sometimes, insufficient stability. From this perspective, small mole-
cules, which can be engineered to target every potential protein of interest, are advantageous
over biomacromolecules. In this regard, natural-like small scaffolds or peptidomimetics bear
the potential of combining the benefits of both approaches: favorable pharmacokinetic proper-
ties of small molecules and the convenient tailoring of biomacromolecules to disrupt protein-
protein interactions. Also extensively used to mimic discontinuous recognition epitopes in pro-
teins are phage display techniques, which provide with linear peptides and simple cyclic pep-
tides to target protein-protein interfaces [17–19]. Moreover, small chemical scaffolds such as
triazacyclophane have been used to covalently attach discontinuous binding epitopes without
further spatial arrangement considerations [20, 21].
A plausible strategy to successfully transfer a large protein recognition site of non-structured
and discontinuous nature into a small scaffold in a straightforward manner consists on first
identifying a minimum set of functionalities relevant for the molecular recognition, secondly,
having in hand a small scaffold able to present the desired functionalities in a suitable three-
dimensional (3D) arrangement and to accommodate all chemical features necessary for stabil-
ity and good complementarity to the targeted site so that it can achieve potent binding affinity.
Bringing all these components together constitutes a quite arduous path, and, in order to ease
this process, the speedy selection of a suitable scaffold is definitively a determinant step. Once
such ideal scaffold is in place, a right design rationale strategy is crucial to bringing it into the
final desired molecule effectively mimicking the targeted recognition site.
Naturally occurring scaffolds such as β-hairpins, α-helices and structured turns of known
protein structures offer a plethora of combinations of chemical functionalities disposed in a
particular manner in 3D space and, therefore, they represent a great source of such ideal molec-
ular templates. Thus, protein structure repositories such as the Protein Data Bank (PDB) can
be used as a source of seeding templates to ease de novo design strategies for tackling challeng-
ing protein binding epitopes.
Here, we report a minimalist computational structured-based approach to ease the de novo
design of small scaffolds mimicking challenging protein recognition epitopes of large, non-
structured and discontinuous nature. Our methodology is based on regular expressions signify-
ing the three-dimensional disposition of functionalities of a small set of residues (not continu-
ous in the protein sequence) relevant for molecular recognition in a targeted binding site, and
it is inspired on the commonly used PROSITE pattern syntax [22, 23]. Our regular expressions
are used to query the PDB for matches to small regular architectures in known proteins. Those
architectures able to accommodate the desired functionalities in a suitable 3D arrangement are
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considered as candidate seeding templates to lead a rational structure-based rescaffolding
design strategy to develop molecules that can effectively mimic the targeted recognition site.
We have applied this innovative and simple rescaffolding approach to de novo design of a
new class of potent interleukin 10 (IL-10) ligands that mimic the high affinity receptor IL-
10R1. This protein-receptor system constitutes a clear example of a challenging molecular
interface in terms of receptor mimicry. IL-10 is a pleiotropic cytokine that plays a crucial role
in modulation of immune response and pathological inflammatory processes [24–26]. Struc-
turally, IL-10 consists of a symmetric homodimer of two alpha-helical domains [27], and its
biological function is modulated by interactions with two cell surface receptors: IL-10R1 (high
binding affinity) and IL-10R2 (low binding affinity). The high-resolution 3D crystal structure
of IL-10 in complex with IL-10R1 exhibits a quite large binding interface (ca. 800 Å2) in which
the receptor side comprises several discontinuous patches of unstructured nature [28]. To our
knowledge, the defiant endeavor of designing small regular architectures as IL-10R1 mimetics
has not been previously accomplished. Our work represents a successful example on how to
ease the path from discontinuous unstructured protein regions to small regular natural-like
architectures in de novo rational design of protein mimetics.
Results and Discussion
Downsizing the binding epitope to a minimal functional descriptor in 3D
The recognition of IL10-R1 by IL-10 involves 23 receptor residues (S1A and S1B Fig) [28]. The
particularly discontinuous arrangement of these residues in sequence, and their quite scattered
disposition in 3D space along ca. 34 Å, makes it quite challenging to assemble all their func-
tionalities within a small molecule able to mimic the IL-10R1 interaction to IL-10. Based on
available structural data [28], residues IL-10R1Y43, IL-10R1R76, IL-10R1R96, IL-10R1S190 and
IL-10R1R191 have been proposed as being the most relevant for protein-receptor recognition.
Our energetic calculations (see materials and methods) confirmed those residues as being the
major contributors to the energy of binding of IL-10R1 to IL-10 (S1C Fig).
In our approach, as strategy to ease the definition of key functionalities in the targeted bind-
ing site, we downsized the number of residues to be taken into account by a selection procedure
based on: i) calculated residue binding energy contribution, ii) interfacial hydrogen bond net-
work with IL-10, and iii) proximity in space. Based on these criteria, residues IL-10R1Y43,
IL-10R1R76 and IL-10R1R96 (S1 Fig), which exhibited top binding energies, an extensive inter-
facial hydrogen bond network with IL-10 and were disposed in close proximity in space (all
within 12 Å), were considered as key functionalities for our seeding template search. Though
downsizing the large binding epitope to three residues would imply at first none or consider-
ably low binding affinity of any seeding templatemolecule containing them, the geometric and
functional constraints demarcated by the side chains of the selected residues would constitute
the minimal 3D functional descriptors to generate regular expressions signifying relevant func-
tionalities of the targeted recognition site to be mimicked (Fig 1).
3D Regular expressions describing minimal 3D functional descriptors
The task of searching through repositories of protein structures is considerably more difficult
than searching through protein sequence databases. The overall amount of flexibility in protein
structures varies considerably, with certain substructures remaining relatively rigid, while oth-
ers undergo considerable natural variation. Specifying a motif as a specific spatial arrangement
of residues has certain weaknesses: firstly, in the computational difficulties of identifying
matches, and secondly, in allowing enough flexibility in the pattern so that it can match a
broad and meaningful set of structures. The first issue has been addressed in a number of
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studies such as the template library TESS by using geometric hashing techniques [30] or Jess,
which builds on the previous approach by using a back tracking algorithm [31]. Flexibility in
the geometric constraints has been previously included as an overall threshold in the accepted
RMSD between template and matches structures [32–38]. Our approach to the protein struc-
ture search problem has been to develop a procedure that allows us to define structural rela-
tionships between flexible sequence patterns. For this, we have taken the commonly used
sequence-based PROSITE syntax [22, 23] as bases to formulate a 3D pattern syntax, which
allows a minimalist representation of relationships in 3D space among functionalities without
the necessity of introducing any template coordinates as input file (see materials and methods
for details).
The above-mentioned 3D functional descriptors and the geometric relationships among
them has been used to generate the 3D syntax query R-<2,6>-R-<4,5>-Y-, which incorpo-
rates the selected key functionalities distributed in 3D as desired. Functionalities (side chains)
are specified in our search interface as pseudo-points [39]. In the 3D syntax query, R-<2,6>-R
describes a range of distances (2 to 6 Å) covering all possible spatial relationships among the
side chains of IL-10R1R96, IL-10R1R76a and IL-10R1R76b (being R76a and R76b the two con-
formers found for residue R76 in equal occupancy in the crystal structure). The relation
between the functionalities of the side chains of IL-10R1R96 and IL-10R1Y43, or between one
conformer of IL-10R1R76 and IL-10R1Y43 are described by R-<4,5>-Y. Finally, the hyphen
character “-”at the end of the R-<2,6>-R-<4,5>-Y- query specifies a cyclic pattern that rein-
forces tyrosine functionalities in a way that should be placed in space between the two arginine
functionalities already described by the previous syntax elements (Fig 1).
Fig 1. Template-based rescaffolding strategy. 3D functional descriptors representing the side chain
functionalities of selected IL-10R1 binding residues (yellow sticks) are used to define the 3D pattern syntax
query R-<2,6>-R-<4,5>-Y- to search for seeding templates in PDB. One of the best hits, used as seeding
template (2ACA149-157, in green), is shown superimposed to the selected IL-10R1 relevant residues for
molecular recognition. Molecular images created with PyMOL [29].
doi:10.1371/journal.pone.0154046.g001
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Search and identification of seeding templates
Our approach uses a 3D pattern query and a search algorithm to scrutinize the PDB. The mil-
lions of atomic coordinates collected in the PDB (ca. 115.000 experimentally obtained macro-
molecular structures) and organized in different 3D topologies accommodating endless
combinations of functionalities are exploited to identify small regular architectures matching
the selected 3D functional descriptors (see materials and methods for details).
The scrutiny of the PDB by our search engine with the query R-<2,6>-R-<4,5>-Y- threw
off a total of 102 matches to our 3D functional descriptors (S1 Table). Only those hits contain-
ing the desired descriptors in a well-defined or regular secondary structure were considered.
Furthermore, we selected the shortest architectures (up to 10 residues long) and, by rejecting
those that were redundant, we were left with seven candidate structural motifs (Table 1). Inter-
estingly, these contained helical structures, indicating that a helix-like architecture could be
considered as a suitable scaffold to achieve an appropriate 3D disposition of the required func-
tionalities. Alpha-helical scaffolds are very attractive from the design point of view as they can
be easily stabilized by chemical modifications and, furthermore, they offer many possibilities
for substitutions [8, 10, 11]. The selected seven structural motifs were manually superimposed
on the X-ray structure of the IL-10/IL-10R1 complex such that a maximal overlap of their func-
tionalities with the selected IL-10R1 binding residues was achieved (Fig 1). Those motifs with
best atomic overlapping, 2ARZ105-109, 1ZYL127-131 and 2ACA151-155, were selected. These
superposition models were used to analyze which motif would provide the possibility of intro-
ducing additional functionalities such that they would engage in the maximum number of
complementary interactions with IL-10. In this line, we adopted a straightforward strategy con-
sidering the possibility to elongate the alpha helix at the N- and C-termini. 1ZYL127-131 and
2ACA151-155 were disposed longitudinally with respect to the protein-receptor interface,
whereas 2ARZ105-109 was transversally oriented (S2 Fig). The longitudinal orientation was able
to provide a larger number of interactions with the protein when considering the N- and C-
terminal elongation of the helical scaffold. Therefore, the 1ZYL and 2ACA structural motifs
were taken into account with two and five additional residues at the N- and C-termini, respec-
tively, which were already in helical conformation in their respective PDB structure. The result-
ing dodecameric helical scaffold X1X2R3Y4X5X6R7X8X9X10X11X12 (being X any amino acid and
underlined positions those representing the 3D functional descriptors) was considered as seed-
ing template for further design purposes. Its model in complex with IL-10 was used to investi-
gate in atomic detail those positions that would allow structure-stabilizing chemical
modifications excluding positions 3, 4 and 7, which resemble the relevant functionalities of IL-
10R1 for IL-10 recognition.
Table 1. Residues in PDBmatching the 3D pattern syntax query R-<2,6>-R-<4,5>-Y-. They are under-
lined in their corresponding PDB structural motifs.
PDB ID (Å) Residues matching query Structural motif
2ARZ (2.0) R108/R105/Y109 105-RYYRY-109
2G2X (2.3) R39/R35/Y32 32-YQARNFLR-39
1UFA (2.2) R86/R83/Y79 79-YAKDRLER-86
1XWM (2.5) R188/ R192/Y189 188-RYIER-192
1ZYL (2.8) R131/R127/Y128 127-RYLGR-131
2ACA (2.2) R155/R151/Y152 151-RYRER-155
3KH5 (2.1) R76/R71/Y67 67-YNLIREKHER-76
doi:10.1371/journal.pone.0154046.t001
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Rational design strategy and experimental validation
Structure-based design of first generation IL-10R1 mimetics. Peptides of less than 15
residues derived from sequences present in protein helical domains usually lack such confor-
mation when they are taken out of the stabilizing environment of the protein. Several
approaches have been developed to stabilize short peptides into alpha helical conformations.
The formation of covalent linkages between adjacent residues has been one of the preferred
methodologies [3–5, 8, 10, 11]. In this regard, lactam bridges between the side chains of lysine
and aspartic acid in positions i,i + 4 have been shown to stabilize most efficiently short syn-
thetic peptides into an alpha-helical structure [40]. We therefore adopted a lactam bridge
design strategy. Our 12-mer seeding template X1X2R3Y4X5X6R7X8X9X10X11X12 (vide supra)
offers the possibility to accommodate two i,i + 4 lactam bridges, which, in order to fix the
desired conformation of positions 3, 4 and 7 with respect to IL-10 (i.e. in two consecutive heli-
cal turns), could be introduced separately or consecutively: [K1X2R3Y4D5]
X6R7[K8X9X10X11D12] and [K1X2R3Y4D5][K6R7X8X9D10]X11X12, respectively (square brackets
represent lactam bridges between lysine (K) and aspartic acid (D) side chains) (S3A and S3B
Fig). In the first scenario, the twelve residues would be constrained in helical conformation. In
the second, only residues 1 to 10 would be constrained. Nevertheless, the helical conformation
could be extended beyond these constraints at least by one or two more residues [41]. Based on
our 3D molecular models, the first option would offer only position 11 for introducing addi-
tional H-bond interactions with IL-10, whereas in the second option positions 8 and 11 would
be available. In addition, our models suggested that the region of IL-10 interacting with the res-
idue in position 11 (loop AB) would require certain flexibility in its counterpart. Therefore,
two consecutive i,i + 4 lactam bridges were introduced in the scaffold resulting in a bicyclic
molecule, which was then subjected to a per residue structure-based mutagenesis process in
order to achieve best binding complementarity to IL-10. Here, substitutions at positions 3, 4, 7,
8 and 11 pointed towards IL-10, whereas residues at positions 9 and 12 did not establish con-
tacts with the protein, and they were therefore maintained unaltered as in the corresponding
PDB template structure (2ACA149-160). Position 12 could be used to enhance helicity in the C-
term. Following this rationale, a lysine residue was introduced at position 8 to favor interac-
tions with IL-10D44, and position 11 was used to introduce an arginine side chain for interac-
tions with IL-10D44 and IL-10Q42 (S3C Fig). In order to analyze the possibility that the four
positive charges so-far introduced in our bicyclic template could engage in non-specific electro-
static interactions at other regions of IL-10, we performed energy interaction calculations with
a sp2 amine NH2 cation and a sp
3 amine NH3 cation chemical probes by using GRID [42]. The
most favorable energy was obtained at the predicted binding region for our template (S4A Fig),
suggesting that the selected topology of charged residues would confer sufficient binding speci-
ficity to the designed molecule.
At this first stage, our rational design strategy also included additional strategic residue
modifications directed towards the experimental evaluation of ligand binding at the protein
targeted site by means of fluorescence spectroscopy (vide infra). A tryptophan or its 5-hydroxy
derivative were introduced at position 2 of our ligands as labels to enable monitoring of protein
complex formation. Furthermore, in order to enhance the sensitivity of tryptophan fluores-
cence measurements upon ligand binding at the targeted site, our rationale also made use of a
mutation of cysteine to tyrosine in the protein binding region (i.e. at position 149, see below
and Fig 2 for details). Thus, we could anticipate that, in case of ligand binding to the protein in
the targeted site, the tryptophan emission produced would be enhanced by an energy transfer
from the neighbor protein residue Y149. Finally, our template was acetylated and amidated in
its N- and C-termini, respectively. The resulting IL-10R1 mimetic molecule Ac-[KW2R3Y4D]
De Novo Design of IL-10R1 Mimetics
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[KR7K8VD]R11A-NH2 (M1, Table 2, Fig 2) was refined in complex with IL-10 using MD simu-
lations (see materials and methods for details). The mimetic-protein binding free energy
(ΔGM-P) was estimated with the MM-PBSA method and indicated favorable electrostatic and
van der Waals contributions to the binding [43, 44] (Table 2). Hydrogen bonding between
both molecules was evaluated (S2 Table). In the refined model, R3 participated in a hydrogen
bond with IL-10D144, Y4 with IL-10K138 and IL-10E142, R7 with IL-10Q38 and IL-10D41. K8 and
R11 formed hydrogen bonds with IL-10D44. Furthermore, the aliphatic moieties of the R3, Y4
and R7 side chains of the mimetic showed important van der Waals contributions with the side
chains of IL-10I145 and IL-10Q38. The relevance of mimetic residues Y4, R5 and R7 in binding to
IL-10 was further investigated by MM-PBSA alanine mutagenesis [43–45]. The substitution of
these residues by alanine revealed a considerable unfavorable effect in binding for all mutants,
showing the most dramatic effect for alanine mutation at position 7 (R7A, S3 Table).
Fig 2. Structure-based design rationale. (A) Atomic representation of the model of the complex between IL-10 (gray, PDB ID 1J7V) and the helical scaffold
used in the rationale for the design of IL-10R1mimetics (green,N-terminal functionalization in yellow). For clarity, no side chains shown for IL-10Q38 and IL-
10L48. (B) Snapshot of complex IL-10/M1 (at 2.9 ns from 10 ns MD simulation). (C) Snapshot of complex IL-10/M4 (at 10 ns). (D) Snapshot of complex IL-10/
M6 (at 3.6 ns). Residues involved in recognition are shown in sticks and colored by atom type (IL-10 highlighted in violet in A). Red spheres represent
interfacial structural waters observed during MD simulations. Intermolecular H-bonds are depicted by black dashed lines. Figure generated in PyMOL [29].
doi:10.1371/journal.pone.0154046.g002
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Experimental validation of first generation IL-10R1 mimetics. M1 was chemically syn-
thesized, and its experimental binding affinity towards IL-10 was assessed by thermal stability
measurements using circular dichroism (CD) [46] and fluorescence [47] (see materials and
methods). For these studies, we used the readily available murine IL-10 mutant mIL-10C149Y in
which Cys149 was replaced by the corresponding Tyr residue of the human protein, as it was
previously shown to enhance protein refolding yield [48, 49]. Furthermore, this tyrosine would
enhance the sensitivity of tryptophan fluorescence measurements (i.e. as stated above, it can
act as energy donor for the tryptophan residue introduced as label in the mimetics).
Human and murine IL-10 share high sequence similarity (88%), and the residues forming
the mimetic binding site are conserved in both. Furthermore, the selected IL-10R1Y43,
IL-10R1R76 and IL-10R1R96 binding residues used for our design are fully conserved in both
human and murine receptors. The 3D structure of mouse IL-10 and its receptor are not avail-
able. Therefore, in order to investigate the suitability of the use of mIL-10C149Y for our studies,
and for comparison purposes between the murine and human proteins, atomic models of mIL-
10C149Y and mIL-10R1 were built by applying homology modeling techniques (see materials
and methods for details and S5 Fig). The obtained 3D mouse models were analyzed in detail in
context of the crystal structures of human IL-10 and its complex structure with IL-10R1 to
investigate any structural differences, in particular at the recognition site (S5 Fig). In mIL-
10C149Y, most residues involved in the mimetic binding interface are conserved in sequence
and 3D space disposition. Residues mIL-10Q32 (R in human, helix A), mIL-10T39 (M in human,
helix A) and mIL-10T49 (K in human, loop AB), although not conserved, were not exposed to
the mimetic and, therefore, were not expected to interfere with its binding. Residue mIL-10N141
(S in human IL-10, helix F’) is located at the recognition site of the conserved receptor residues
mIL-10R1R76 and mIL-10R1R96, and it could therefore establish similar interactions as in
human IL-10. mIL-10I46 (L in human IL-10, loop AB) is semi-conserved and would participate
in van der Waals interactions with mIL-10R1Y43 as in the human protein-receptor complex.
mIL-10D50 (E in human, helix B) is also semi-conserved and could participate in additional
interactions with the N-terminally elongated IL-10R1 mimetics. Based on the sequence and
structural similarity of the mimetic recognition site in the human and mouse proteins and the
receptors, we concluded that mIL-10C149Y could appropriately serve our experimental needs,
and that the designed IL-10R1 mimetics should also bind to it as predicted for the human
protein.
Table 2. Mimetic-protein binding free energy obtained by MM-PBSA [43, 44] and experimental dissociation constants (Kd).[a],[b]
IL-10R1 Mimetic Sequence ΔGM-P (kcal/mol)
[c] Kd (μM)
M1 Ac-[KWRYD][KRKVD]RA-NH2 -27.1 ± 6.6 > 30
[a]
M2[d] X-[KWRYD][KRKVD]RA-NH2 -53.3 ± 9.9 5.0
[a]
M3[d][e] X-[KZRYD][KRKVD]RA-NH2 -59.9 ± 9.2 6.7
[a]
M4 Ac-R[KWRYD][KRKVD]RA-NH2 -59.2 ± 7.0 8.4
[a]
M5 Ac-EK[KWRYD][KRKVD]RA-NH2 -77.9 ± 9.7 0.07 ± 0.02
[b]
M6 Ac-ER[KWRYD][KRKVD]RA-NH2 -71.8 ± 8.0 0.04 ± 0.02
[b]
[a] Kd values calculated from thermal denaturation data.
[b] Kd values inferred from ITC thermodynamic data.
[c] ΔGM-P = Mimetic-Protein binding free energy. Entropy contribution to binding was not estimated here.
[d] X = 4-guanidinobutanoyl.
[e] Z = 5-Hydroxy-L-tryptophan.
doi:10.1371/journal.pone.0154046.t002
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The experimentally estimated binding affinity shows thatM1 binds to the protein (Table 2,
Figs 3 and 4). Complex formation betweenM1 and mIL-10C149Y was determined by thermal
denaturation using CD and the well-known negative ellipticity of IL-10 between 200 to 300 nm
[40]. The average CD signal in this range of wavelengths was measured as a function of temper-
ature between 298 and 363 K. Fig 3A shows a decrease of negative ellipticity, which exhibits a
sigmoidal shape typical of thermally induced protein unfolding. The obtained curves shift to
higher temperatures in the presence ofM1. The shift is due to a lower degree of unfolded pro-
tein at any temperature in the presence of mimeticM1 as compared to the denaturation of
mIL-10C149Y alone. The largest difference was observed at 332 K and is expressed in percentage
of the total unfolding signal (obtained after subtraction of the initial and final linear segments
of the curves). At 332 K, the presence ofM1 increased the native protein structure by 8%.
Fig 3. Temperature denaturation curves obtained by CD for mIL-10C149Y in complex with IL-10R1
mimetics M1-M4. The average thermal denaturation CD signal in the 215 to 230 nm range is plotted as a
function of temperature for mIL-10C149Y alone (2 μM, red open circles) and for mIL-10C149Y in the presence of
each mimetic M1-M4 (4.5 μM, black filled squares) in panels A-D, respectively. The obtained mIL-10C149Y CD
data agree with those published earlier for human and murine IL-10 [50]. The highest amount of native protein
structure binding to each of the mimetics M1-M4 was observed at 332 K (dashed lines) and is given in each
corresponding panel as percentage of the total change in the CD-signal.
doi:10.1371/journal.pone.0154046.g003
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Fig 4. Temperature-dependent excitation spectra of the tryptophan in mimetics M1-M4.Upper plots
A-D: Mimetic tryptophan emission (excited between 200 and 290 nm) measured at 360 nm for the
temperature range between 298 K and 363 K for each mimetic M1-M4 in the presence of mIL-10C149Y. The
excitation spectra at 332 K are highlighted in red. Lower plots A-D: Subtraction of the excitation spectra at 298
K from those at 332 K (red) in comparison with the spectra obtained in absence of mIL-10C149Y (blue).
doi:10.1371/journal.pone.0154046.g004
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Simultaneously with the thermal stability CD-signals, the excitation spectrum of the trypto-
phan residue strategically introduced at position 2 inM1 was measured. The results obtained
provided an additional assessment of complex formation betweenM1 and mIL-10C149Y (Fig
4A). We observed that the emission at 360 nm decreased with increasing temperatures, leading
to the decline of the excitation spectra between 200 and 290 nm (Fig 4A upper plot, excitation
spectra at 332 K highlighted in red). The underlying spectral differences are clearly appreciated
in the representation of the subtraction of the excitation spectrum at 298 K from that at 332 K
in the presence and absence of mIL-10C149Y (Fig 4A lower plot, red and blue line, respectively).
The enhanced temperature sensitivity of tryptophan fluorescence obtained in the presence of
mIL-10C149Y supports a binding interaction. The increased fluorescence emission is explained
by a restriction in movement of the indole ring at the binding interface and the energy transfer
from Y149 in mIL-10C149Y. Both factors would vanish upon thermal denaturation, leading to
the observed larger drop in fluorecence excitation in the presence of mIL-10C149Y. These data
therefore support the interaction ofM1 with mIL-10C149Y as derived from the CD-denatur-
ation curves.
Rational optimization of first generation IL-10R1 mimetics and experimental valida-
tion. Two iterative cycles of in silico optimization and experimental validation were carried
out with the purpose of increasing the interactions betweenM1 and IL-10 and, therefore,
obtain potent IL-10R1 mimetics.
By comparing the structures of the refined model complex IL-10/M1 and the X-ray struc-
ture of IL-10/IL-10R1, it was envisaged that N-terminal functionalization ofM1 could poten-
tially contribute with additional complementary interactions to the protein. Indeed, in the MD
simulation of the IL-10/IL-10R1 complex the following interactions were observed: IL-
10R1N73/IL-10E50, IL-10R1N73/IL-10L48, IL-10R1D100/IL-10R27 and IL-10R1E101/IL-10K34.
Thus, based on the structure of the refined model of theM1/IL-10 complex (Fig 2A and 2B)
and taking into account the interaction energies obtained with the sp3 and sp2 amine cation
chemical probes (vide supra), two new mimetics (M2,M3; differing in tryptophan vs. its
5-hydroxy derivative in position 2) were designed by N-terminal functionalization with 4-gua-
nidinobutanoyl, providing a positively charged H-bond donor for potential interaction with
the negatively charged side chain of IL-10E50 (helix B). The same holds true for the extension of
the N-terminus ofM1 by an arginine (M4) or lysine, which could offer stabilizing interactions
with the backbone of IL10L48 (loop AB) and/or the side chain of IL-10Y149 (helix F’). The bind-
ing affinities of IL-10R1 mimeticsM2,M3 andM4, determined as described forM1 (vide
supra), showed a considerable improvement (Table 2, Fig 3).
As forM1, the obtained fluorescence data for mimeticsM2-M4 clearly revealed enhance-
ment of tryptophan emission when the mimetics were bound to the protein (Fig 4B–4D). As
described above, this is explained by the immobilization of the tryptophan of the mimetics and
the energy transfer from the protein tyrosine in position 149 upon complex formation, which
support the protein-mimetic interaction at the expected binding site. This piece of evidence
supported our design rationale.
Further ligand optimization was accomplished by the introduction of an additional N-ter-
minal H-bond acceptor such as Gln or Glu (M5,M6), which would allow interactions with the
cationic side chains of IL-10R27 and IL-10K34 (helix A) or with IL-10N148 (helix F’) (Fig 2A).
Favourable energies obtained for the interaction of IL-10 with an aliphatic carboxylate chemi-
cal probe [42, 51] supported this rationale. Furthermore, residues IL-10L46 (loop AB) and IL-
10I145 (helix F’) would additionally contribute with van der Waals interactions with the ali-
phatic moieties of the side chains of the residues introduced at the N-teminus. The computa-
tionally obtained binding free energies and the experimental Kd estimates (Table 2) showed
correlation and a clear improvement in binding due to N-terminal functionalization, reaching
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nanomolar affinities forM5 andM6 as determined in more detail by isothermal titration calo-
rimetry (ITC, see materials and methods) (Fig 5). Furthermore, these measurements supported
the expected stoichiometry 2:1 mimetic:dimer-protein binding ratio as previously observed for
the IL-10R1/IL-10 complex [28].
All in all, the step-wise increase in binding obtained computationally and experimentally
for the designed molecules along our iterative rational strategy support the design rationale.
The analysis of the interfacial H-bond formation observed along the corresponding MD tra-
jectories of the protein-mimetic complex series (see materials and methods) corroborated the
envisaged interaction patterns. First, the introduction of new H-bond donors at the N-termi-
nus ofM1 led to complementary interactions with acceptor groups of protein residues L48,
E50, E142 and Y149 (M2-M4, S2 Table, Fig 2C). Second, the N-terminal extension by an addi-
tional residue acting as an H-bond acceptor (M5 andM6) allowed interactions with the donor
groups of protein residues K34, Q38 and N148 (S2 Table, Fig 2D). The data obtained from the
MD trajectories were also used to analyze the dynamic behaviour of solvent, in particular those
water molecules that were participating in the binding of the mimetics to the protein. In the
case of mimeticsM3 andM4, a well-defined water molecule was observed bridging by H-bond
their guanidinium groups in X and R-1, respectively, with the protein residues L48 and E142
(S2 Table). InM5, a water molecule located in the mimetic-protein interfacial core was
observed to bridge residue Y4 and protein residues D41 and S141. Bridging water molecules
were also involved in interactions between residue R3 inM6 and protein residue S141 (S2
Table, Fig 2D). These observations highlight the relevance of interfacial solvent for the protein-
mimetic recognition, as demonstrated for other PPIs [52–54], and the importance of the
Fig 5. Isothermal titration calorimetry. (A) mIL-10C149Y (43 μM) with M5. (B) mIL-10C149Y (25 μM) with M6.
Upper and lower panels show the raw data and integrated heat changes with the corresponding fitted binding
curves based on a single site model, respectively.
doi:10.1371/journal.pone.0154046.g005
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solvation effect for ligand recognition [55]. Furthermore, per residue energetic contributions
obtained fromMM-PBSA indicated favourable hydrophobic contributions. The most relevant
van der Waals interactions were observed between the aliphatic moieties of K-1, R-1, X, R3, Y4,
K8 ofM2-M6 and the protein residues D44, L46, D144 and I145 (S6 Fig). The aliphatic moiety
of residue R7 in the mimetics also contributed to hydrophobic interactions with the protein res-
idues Q38 and Q42. The results obtained from the MM-PBSA alanine scanning carried out on
the residues R3, Y4 and R7 in mimeticsM4 andM6 were consistent with the decrease in protein
binding observed for these mutations inM1 (S3 Table). MimeticsM2,M3 andM4 incorporat-
ing one H-bond donor at the N-terminus ofM1 showed Kd values below 10 μM, reflecting an
enhancement of binding higher than 6-fold in the best case with respect to the leadM1. The
maximal binding enhancement was obtained forM5 andM6, which showed binding affinities
values in the nanomolar range, corresponding to a more than 70-fold increase with respect to
M2-M4, and at least more than 400-fold with respect toM1. Thermodynamic parameters
determined from ITC measurements for the most potent designed IL-10 ligands (M5 andM6)
indicated that their free energies of binding were mostly driven by a favourable entropic com-
ponent (TΔS 9.5 kcal/Kmol) with a weak favourable enthalpic term (ΔH -0.5 kcal/mol). The
observed favourable entropic contribution was attributed to the intrinsic rigid structural nature
of the protein, the pre-organized helical nature of the mimetic, as described for other structur-
ally constrained systems [56, 57], the van der Waals interactions established between several
protein and mimetic residues, and the presence of structural bridging waters involved in pro-
tein-mimetic binding. The latter was further investigated by analyzing the overlap of the inter-
action energy maps obtained for the unbound IL-10 (PDB ID 2ILK (1.6 Å) [27]) with a GRID
“solvent” water and a “solvent exclusion” sp3 carbon chemical probes [42, 54]. A favourable
energy contribution for solvent was indicative of the presence of three water molecules at the
mimetic binding site, which, interestingly, overlapped with three structural waters present in
the crystal structure of the free IL-10. Furthermore, the “solvent exclusion” probe provided one
of the largest energetic contributions in the same region where these waters are located (S4B
Fig). This analysis further indicates an entropic contribution resulting from the release of struc-
turally bound water molecules upon mimetic binding.
Conclusions
The plethora of information currently contained in the three-dimensional protein chemical
space available in the PDB offers a great ground for identifying defined topologies containing
endless combinations of functionalities in 3D space. This pool of millions of atomic coordi-
nates topologically arranged in 3D space can be exploited to facilitate rescaffolding strategies
for the design of natural-like chemical architectures to tackle challenging protein-protein inter-
actions. A customized regular expression syntax describing particular 3D arrangements of
functionalities relevant for recognition within discontinuous unstructured protein regions has
been developed in order to scrutinize such available structural information of the PDB for
matches to regular structural frameworks already present in nature. The straightforward iden-
tification of adequate seeding structural templates with the desired 3D arrangements of func-
tionalities using this minimalistic approach has been key for a plainspoken and successful de
novo design of a new class of potent molecules that mimic unstructured and discontinuous
regions of receptor IL-10R1 responsible of its high affinity for IL-10. The molecular rational
design approach described here constitutes a step forward towards tackling challenging pro-
tein-protein interfaces because it smoothes existing limitations for mimicry of interactions
spanning large and poorly structured binding epitopes in a sequence-connectivity independent
manner.
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Materials and Methods
3D Pattern regular expression methodology
Our methodology is inspired on the well-established PROSITE syntax commonly used in pro-
tein sequence analysis [22, 23], which consists of a collection of pre-defined sequence profiles
(defining protein families or functional motifs) that is used to find matches in protein sequence
databases. In particular, our methodology involves two technical contributions: a 3D pattern
syntax and a structural pattern search algorithm.
- The 3D pattern syntax developed here uses the PROSITE pattern syntax as starting point.
It contains sequence patterns defining functionalities at residue level, and a variety of structural
connectors defining distance and angle ranges and their inter-relationships (Fig 6). This syntax
allows multiple sequence patterns to be joined using flexible structural connectors. The combi-
nation of all these syntax elements confers flexibility in the definition of sequence and struc-
tural constraints representing desired functionalities in each individual syntax query.
A sequence pattern consists of a definition of one or a combination of amino acids. The later
is represented with square brackets “[]” for allowed residues and curly brackets “{}” for for-
bidden residues. The geometric relationship between sequence patterns in three-dimensional
space is established by using geometrical descriptors, which we call structural connectors. A
structural connector is defined in terms of a range of values: i) distances (in Angstroms)
between the alpha carbons or a functional center of the side chain of amino acids, the latest
denoted as pseudo atoms roughly equivalent to the center of mass of the side chain and
inspired in previous work of Bahar et al [39]; ii) angles (in degrees) formed by the correspond-
ing peptide sequence backbones. The use of pseudo-points represents an advantage over calcu-
lating all pairwise distances, which would considerably increase the calculation time (about 16
times). Distances between alpha carbons or pseudo-points and angles between alpha carbons
Fig 6. 3D pattern syntax: Sequence patterns and structural connectors.
doi:10.1371/journal.pone.0154046.g006
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are specified in the search interface by selecting either alpha-carbons or pseudo-points for each
search. A structural connector is denoted by a pair of angle brackets “<>”. Structural con-
straints can be combined by introducing a pipe-line “|” between connectors. The connection
between two sequence patterns and a structural connector is defined by a hyphen character (i.e.
“-“). A cyclic pattern is built by adding this hyphen at the end of the last sequence pattern or
structural connector.
A particular 3D pattern syntax query defining geometric relationships of desired functional-
ities is used as input by our structural pattern search algorithm.
- The structural pattern search algorithm operates across multiple stages designed to mini-
mize the computational overhead of querying large protein structure datasets (i.e. the Protein
Data Bank PDB) directly.
1. First, and as a pre-filtering step, the search engine utilizes a dataset of sequences (extracted
from the 3D structures to be analyzed; i.e. PDB) for candidate hits matching. A candidate
hit is any protein sequence that has each of the specified sequence elements or sub-
sequences in the pattern. Sub-sequences should not overlap.
2. A data-structure of all available sub-sequences in a given protein (often there are multiple
matches for each sub-sequence) is built by considering all hits obtained in the previous step.
This data-structure is then used in the next stage.
3. The engine verifies that there is at least one set of sub-sequences that matches the required
structural constraints specified in the 3D pattern syntax query. As the combinatorial space
can be extremely large, the engine makes use of a recursive backtracking algorithm to mini-
mize redundant computation and permit early termination when one of the required sub-
sequences has been found to fail all structural constraints.
As multiples matches could be found for the same structure, and in order to improve compu-
tational efficiency and to avoid large numbers of very minor variations, we add the additional
constraint that multiple matches in the same structure cannot overlap any components. In addi-
tion, we run the structural pattern search algorithm over a redundancy reduced data set. When
matches are found, we are able to manually explore similar structures for equivalent matches.
All algorithms developed to interrogate the protein structure space in a systematic manner
searching for patterns in databases have to make a trade-off between three key areas: 1) The
pattern expressivity (i.e. range of functional motifs that can be captured), 2) The ease of pattern
definition, 3) The computational efficiency. In our approach, we scarify some of the first fea-
ture in order to achieve better performance on the latter two. Our methodology presents a
number of key differences with other comparable computational techniques such as RAMOT-
3D [36], ASSAM [37] and IMAAAGINE [38] and overcomes some of their limitations. Typi-
cally, in these tools the search syntax does not allow for variations in the identities of residues
in particular positions as our does. In our case, the patterns are inspired on the PROSITE syn-
tax and therefore defined using amino acid sequence elements. As result easy and flexible pat-
terns can be designed instead of using graphs. Furthermore, our patterns can have arbitrary
numbers of amino acids containing distance and angle tolerances described for each connec-
tion instead of being globally defined. Besides, the chemical properties in our patterns are
defined in our case only through sets of amino acids and not via many pre-defined sets.
Computational structure-based design and simulation
We used the 3D crystal structure of human IL-10 in complex with IL-10R1 for our calculations
(PDB ID 1J7V, 2.9 Å [28]). This structure contains a protein dimer and two receptor
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molecules. Due to the two-fold axis symmetry in this complex, only one of the two IL-10
domains and a receptor molecule were considered for our studies (S1 Fig).
Analysis of relevant binding residues in the IL-10/IL-10R1 interface. To determine the
receptor residues being the major contributors to the protein binding energy, molecular
dynamics calculations were carried out with the IL-10/IL-10R1 complex. AMBER11 and
AMBER12 packages [58] were used for the simulations, and the MM-PBSA method [43, 44] as
implemented in AMBER11 was used to obtain per residue energy contributions (S1C Fig). The
ff99SB force field [59] and standard protocols as implemented in the AMBER11 and
AMBER12 packages were used (see below) [58]. The IL-10/IL-10R1 complex was solvated in a
truncated octahedral box of TIP3P water molecules and neutralized with Cl- counterions.
Molecular dynamics simulations were preceded by two energy-minimization steps: i) only the
solvent and ions were relaxed; ii) the entire system was minimized. The system was then heated
up from 0 K to 300 K in 50 ps. Weak position restraints (10 kcal/molÅ2) were used for the
whole system in the canonical ensemble (NVT). Langevin temperature coupling with a colli-
sion frequency γ = 1 ps−1 was used at this step. The system was equilibrated without restraints
at 300 K during 100 ps in the isothermal-isobaric ensemble (NPT) followed of other 100 ps in
the canonical ensemble (NVT). The Langevin thermostate and Berendsen barostat under peri-
odic boundary conditions were used during the equilibration steps. After this, a total of 20 ns
MD production without restraints was carried out at 300 K in the canonical ensemble (NVT)
using the Langevin thermostat. The SHAKE algorithm was used to constrain all bonds involv-
ing hydrogen atoms. A time step of 2 fs was used. A cutoff of 8 Å was applied to treat the non-
bonded interactions, and the Particle Mesh Ewald (PME) method was used to treat long-range
electrostatic interactions. MD trajectories were recorded every 2 ps. Trajectories were visual-
ized with VMD [60] and evaluated in terms of intermolecular H-bonds using the PTRAJ and
CPPTRAJ modules implemented in AMBER. The criterion used to consider a dynamic hydro-
gen bond formation was to be found at least 10% of the simulation time using a distance accep-
tor-donor cutoff of 3.5 Å and a 120° angle cutoff.
Mimetic refinement and analysis. In each step of the lactam bridge design strategy (S3
Fig), a brief minimization was performed with MOE (Amber12:EHT force field and default
parameters were used) [61]. Molecular dynamics simulations of the complex of IL-10 with
each of the designed IL-10R1 mimetics were performed using the ff99SB force field [59] and
standard protocols as implemented in the AMBER11 and AMBER12 packages (see below)
[58]. The mimetic residues Lys and Asp involved in lactam bridges were parametrized accord-
ing to the ff99SB force field, and RESP charges were derived at the HF/6-31G calculation level
using Gausian09 [62–64]. Same strategy was followed for parameters of the chemical groups
introduced in the optimization process that were not included in the ff99SB force field. Each
protein-mimetic complex was solvated in a truncated octahedral box of TIP3P water molecules
and neutralized with Cl- counterions. Molecular dynamics simulations were preceded by two
energy-minimization steps: i) only the solvent and ions were relaxed; ii) the entire system was
minimized with low position restraints (10 kcal/molÅ2) for the helical backbone section of the
mimetic. The system was then heated up from 0 K to 300 K in 20 ps. Weak position restraints
(10 kcal/molÅ2) were used for the protein and the mimetic in the canonical ensemble (NVT).
Langevin temperature coupling with a collision frequency γ = 1 ps−1 was used at this step.
Along three equilibration steps of 500 ps each, the helical backbone position restraints and also
two distance restraints between protein and mimetic (IL-10Q38/MR7 and IL-10K138/MY4) were
consecutively decreased (10, 5, and 2 kcal/molÅ2, respectively). This was carried out in the iso-
thermal-isobaric ensemble (NPT) using the Langevin thermostate and Berendsen barostat
under periodic boundary conditions. The system was further equilibrated during 1 ns without
restraints at 300 K under same conditions. After this, a 10 ns MD production was carried out at
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300 K in the canonical ensemble (NVT) using the Langevin thermostat. The SHAKE algorithm
was used to constrain all bonds involving hydrogen atoms. A time step of 2 fs was used. A cut-
off of 10 Å was applied to treat the nonbonded interactions, and the Particle Mesh Ewald
(PME) method was used to treat long-range electrostatic interactions. MD trajectories were
recorded every 2 ps. Trajectories were visualized with VMD [60] and evaluated in terms of
intermolecular H-bonds (including bridging water molecules at the interface between the
designed mimetics and IL-10) and RMSD using PTRAJ and CPPTRAJ modules implemented
in AMBER. The criterion used to consider a dynamic hydrogen bond formation was to be
found at least 10% of the total simulation time (S2 Table). Water molecules connecting func-
tionalities (bridging waters) were also considered for hydrogen bond analysis using a distance
acceptor-donor cutoff of 3.5 Å and angle cutoff of 120°. A structural bridging water was consid-
ered to be participating in H-bond in protein-mimetic complex when was found at least 20% of
the total simulation time (S2 Table). Energy decomposition per residue and binding free energy
post-processing analysis of the trajectories (Table 2) were performed in implicit solvent using
the MM-PBSA method [43, 44] as implemented in AMBER11. The same method was applied
to study the effect of alanine mutation on mimetic residues R3, Y4 and R7 ofM1,M4 andM6 in
complex with IL-10 (S3 Table) [43–45]. Data analysis was carried out with the R-package [65].
In order to ensure that main conclusions inferred from the 10 ns MD simulations main-
tained valid our strategy design, a further 20 ns extension was carried out for the optimized
molecules (i.e. IL-10/M2-M6 complexes, S6B Fig).
GRID calculations. GRID [42, 51] version 22 was used to predict energetically favorable
interactions between IL-10 (PDB ID 1J7V) and the following chemical probes: N2 = (sp2
amine NH2 cation), N3+ (sp
3 amine NH3 cation), COO- (aliphatic carboxylate), and between
the unbound IL-10 (PDB ID 2ILK) and the chemical probes: OH2 (water) and C3 (methyl
CH3 group) (S4 Fig). The GRID box dimensions were set to 51 Å x 58 Å x 46 Å in order to
cover the whole protein for the calculations. A grid spacing of 1 Å was applied. The rest of
GRID input parameters values were used as default.
Structure-based modeling of mIL-10 C149Y. The crystal structure of human IL-10 at high
resolution (PDB ID 2ILK (1.6 Å)) [27] and its complex structure with IL-10R1 (PDB ID 1J7V
(2.9 Å)) [28] were taken as structural templates. Human and mouse proteins and their R1
receptors share high sequence similarities (88% and 73%, respectively). The programModeller
as implemented in Discovery Studio (Accelrys) [66] was used for the modeling. The mouse
receptor was modeled following the same procedure.
Peptide synthesis
Designed IL-10R1 mimeticsM1 toM4 were purchased from GL Biochem (Shanghai, China)
with a purity 95% by analytical rpHPLC. Their purity was re-checked by rpHPLC and MS
before experimental use. MimeticsM5 andM6 were synthesized with purity 95% by analyti-
cal rpHPLC using similar methods as previously reported [67].
All commercial reagents and solvents were used without further purification unless other-
wise specified. Mass spectra (ESI) were obtained on a Micromass Quattro LC or a Waters Xevo
TQ-S mass spectrometer each driven by the Mass Lynx software. Preparative HPLC was per-
formed on a Varian Prepstar system equipped with UV detector (Prostar, Varian) and auto-
matic fraction collector Foxy 200. A Microsorb C18 60–8 column (Varian Dynamax 250 × 21.4
mm) was used as the stationary phase and a binary gradient system of 0.1% TFA/water (solvent
A) and 0.1% TFA/CH3CN (solvent B) at a flow rate of 10 mL/min served as the eluent. The
conditions for the gradient elution are as follows: 0–3 min 90% A, 3–7 min gradient to 30% B,
7–27 min gradient to 65% B, 27–30 min gradient to 95% B, 30–35 min 95% B, 35–40 min
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gradient back to 90% A. Analytical HPLC was done in a Merck Hitachi system consisting of a
L7100 gradient pump combined with a Jasco DG2080 4-line degasser with UV absorption
detection at 220 nm by a Merck Hitachi L7450 diode array detector. The system was operated
by the D-700 HSM software using a Merck Hitachi D7000 interface. A Luna C18 5 μm column
(Phenomenex, 250×4.6 mm) was used as stationary phase and a binary gradient system of
0.1% CF3COOH/water (solvent A) and 0.1% TFA/CH3CN (solvent B) at a flow rate of 1 mL/
min served as the eluent. The programme for elution was as follows: 0–3 min 95% A, 3–25 min
gradient to 95% B, 25–30 min 95% B, 30–35 min gradient back to 95% A.
IL-10R1 mimeticsM5 andM6 were prepared on 0.15 mmol scale by manual stepwise solid
phase peptide synthesis using HBTU/DIPEA activation for Fmoc chemistry [68, 69] on Fmoc-
Ala-Rink Amide MBHA (substitution 0.37 mmolg-1). Fmoc-Ala-Rink Amide MBHA was pre-
pared by Fmoc-deprotection of Fmoc-Rink Amide MBHA (1 g, substitution 0.55 mmolg-1)
resin using the procedure outlined below followed by treating the deprotected Rink Amide
MBHA resin with 1.0 equivalent of Fmoc-Ala-OH (0.171 g), 1.25 equivalents of HBTU (0.261
g), and 2.0 equivalents of DIPEA (187 μL) in DMF (4 mL) for 2 hours. Subsequently, the resin
was filtered off and washed with DMF and CH2Cl2 (DCM) (3×5 mL each). Capping of the
unreacted resin-bound amino groups was accomplished by treatment with a 1:1 (v/v) mixture
of DCM and acetic anhydride. The resin was shaken for 3 min, and the liquid was removed by
filtration. The resin was re-suspended in the capping mixture and shaken again for 7 min.
After filtration the resin was washed with DCM (3×5 mL), and the presence of remaining
resin-bound amino groups was checked using the ninhydrin assay. In the case of positive result,
the capping procedure was repeated [70]. Determination of the loading degree was accom-
plished following the protocol described by Gude et al. [71] using two aliquots of the resin.
About 5 mg of the resin (exact value has to be noted) containing the Fmoc-Ala-OH was placed
into a PP reaction vessel and swollen in DMF (2 mL) for 30 min. The suspension was filtered,
and the resin was treated with 2% DBU in DMF (2 mL) and stirred for another 30 min. The
suspension was filtered into a graduated 10 mL flask, and the resin was washed with CH3CN
(3×1 mL). Each filtrate was added to the flask and, the solution was diluted to 10 mL with
CH3CN. 2 mL of this solution were transferred to a graduated 25 ml flask and diluted with
CH3CN to 25 mL. A reference solution was prepared the same way but without addition of the
resin. The sample solutions were measured against the reference at 294 nm in the UV/Vis spec-
trometer. The loading yield was calculated as follows: Loading (mmol/g)294 nm =
(E×14.214 μmol) / mresin(mg). Finally, the average value of the two aliquots was calculated.
Using the procedure outlined above, loading degrees in the range of 0.37–0.44 mmol/g were
obtained.
Fmoc deprotections were achieved with 2 × 5 min treatments with DMF/Piperidine (1:1).
For each coupling, 4.0 equivalents of amino acid and 4.2 equivalents of diisopropylethylamine
(DIPEA) were employed in each coupling step (20–25 min), except for Fmoc-Asp(OAll)-OH
and Fmoc-Lys(Alloc)-OH, where only 2 equivalents were coupled using HATU and DIPEA
activation. Coupling yields were monitored by quantitative ninhydrin assay [72]. After the first
Fmoc-Lys(Alloc)-OH residue was coupled, the resin was washed with DMF/DCM, and swollen
in DCM. Then, the Ally and Alloc orthogonal protecting groups were removed by treating the
peptide resin with PhSiH3 in DCM (20 equiv) and Pd(PPh3)4 (0.15 equiv.) (2 × 20 min) under
Ar [73]. After that, the peptide resin was successively washed with DCM, DMF, 0.5% w/v
sodium diethyldithiocarbamate in DMF, DMF, and again with DCM. Then, the deprotection
step was monitored by using the ninhydrin test, which gave an intense blue, and by MS. Cycli-
zation was effected on-resin using 2.5 equiv. PyBOP, 2.5 equiv. DIPEA in DMF 0.5 M. The
reaction was newly monitored by the ninhydrin test and MS after small cleavage with 95%
TFA, 2.5% TES, 2.5% H2O. The same procedure was repeated to generate the second cycle. The
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peptide resin was then washed with DMF, MeOH/DCM, DCM, and dried in vacuo for 1 hour.
Peptide was cleaved by using 95% TFA, 2.5% TES, 2.5% H2O (6 mL) for 2 hours. The resin was
then filtered off and the solvent evaporated under a stream of nitrogen. The peptide was precip-
itated with cold diethyl ether. The ether was decanted, and the precipitated peptide was re-dis-
solved in 1:1 acetonitrile/water and lyophilized. Crude peptide was purified by reverse-phase
HPLC and assessed for purity by using the conditions specified above. IL-10R1 mimeticM5: Rt
13.0 min, ESMS observed (calculated): [M+2H]2+ = 942.18 (942.03), [M+3H]3+ = 628.29
(628.36), [M+4H]4+ = 471.49 (471.52); IL-10R1 mimeticM6: Rt 11.9 min, ESMS observed (cal-
culated): [M+2H]2+ = 956.25 (956.04), [M+3H]3+ = 637.83 (637.69), [M+4H]4+ = 478.67
(478.52).
Protein expression and purification
Recombinant murine IL-10 (rmIL-10) was expressed in Escherichia coli (E. coli) Rosetta(DE3)
(Merck) using a pET41b(+) vector (Novagen). For purification purposes, the C-terminal histi-
dine tag (LEHHHHHHHH) of the vector was used. The rmIL-10 coding region was further
modified by replacement of cysteine 149, which is not involved in disulfide bond formation, by
a tyrosine, i.e., the corresponding amino acid in the human IL-10 sequence. That modification
improved protein refolding yield by a factor of 20 as previously shown for rat IL-10 but without
any loss in activity [48]. The C149Y mutation was introduced according to the instructions of
the QuikChange mutagenesis kit (Stratagene). The primers for the introduction of the C149Y
mutation were: forward 5’-CTTCATCAACTACATAGAAGC-3’ and reverse complementary
5’-GCTTCTATGTAGTTGATGAAG-3’. Correctness of the rmIL-10 coding region and intro-
duction of the point mutation were confirmed by DNA sequencing.
E. coli cells were grown at 37°C in a minimal salt medium containing 9.29 g/L sodium sul-
fate, 29.2 g/L di-potassium hydrogenphosphate, 8.14 g/L sodium dihydrogenphosphate dihy-
drate, 1.2 g/L magnesium sulfate, 5 g/L glucose, 1 g/L ammonium chloride, 4.92 g/L
ammonium sulfate, 100 μg/mL thiamin, 100 μg/mL kanamycin, and 34 μg/mL chlorampheni-
col. Protein expression was induced with 1 mM isopropyl-β-D-thiogalactopyranoside (IPTG)
and was conducted for 4 hours. The cell pellet was resuspended in 50 mM Tris-HCl (pH 7.4),
100 mM NaCl, 1 mM EDTA, 0.1 mM PMSF, and cells were lysed by using a french press and
by adding 0.3 mg/mL lysozyme. rmIL-10 was obtained in E. coli inclusion bodies which were
washed three times in 50 mM Tris-HCl (pH 7.4), 1 M NaCl, 5% (v/v) Triton X-100, 1 mM
EDTA and finally dissolved in 50 M Tris-HCl (pH 7.4), 100 mM NaCl, 6 M guanidine hydro-
chloride, 200 mM dithiothreitol, 1 mM EDTA. Prior to refolding of rmIL-10, dithiothreitol
was removed by dialysis against 100 mM Tris-HCl (pH 9.0), 100 mM NaCl, 6 M guanidine
hydrochloride. Protein refolding was initiated by rapid dilution into 100 mM Tris-HCl (pH
9.0), 100 mM NaCl, 1 M L-arginine, 5 mM reduced glutathione, 1 mM oxidized glutathione
until a final protein concentration of 0.1 mg/mL was reached. Protein aggregates were immedi-
ately removed by filtration of the protein solution through a 0.45 μm nitrocellulose membrane.
Refolding was allowed to further proceed for two days.
The rmIL-10 was purified using a Ni-NTA agarose column (Machery-Nagel) equilibrated
in 20 mM sodium phosphate (pH 7.4), 50 mM NaCl and was eluted using the same buffer con-
taining 600 mM imidazole. The native rmIL-10 dimer was separated from the monomer and
higher molecular aggregates, which form during protein refolding, using a S-200 HR (GE
Healthcare) preparative gel filtration column equilibrated in 20 mM sodium phosphate (pH
7.4), 50 mMNaCl. Sample purity and identity were confirmed by SDS-PAGE, N-terminal
Edman sequencing and MALDI-TOF mass spectrometry, respectively. Structural integrity of
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rmIL-10 was confirmed by NMR spectroscopy including the resonance assignments of the pro-
tein backbone and Cβ side chain atoms [49].
Circular Dichroism (CD) and Fluorescence Spectroscopy
CD spectra were recorded with a J-815 instrument (Jasco, Gross-Umstadt, Germany) from 195
to 300 nm in 1-cm cuvettes at concentrations of 2 μM of mIL-10C149Y (dimer) and 4.5 μM of
mimeticsM1-M4. Ellipticity θ was recorded in millidegrees. Samples were heated from 298 to
364 K at a rate of 2 K/min under constant stirring to determine stabilization of IL-10/mimetic
complexes. Estimates of binding affinities were derived with the assumption of a two state
unfolding of mIL-10C149Y. The mimetics were assumed to stabilize exclusively the folded state.
These simplifications allow applying equilibrium thermodynamics, such that the fraction Sn of
the native state of mIL-10C149Y can be approximated: Sn = (1+ [M] Kd
-1 +Ku)
-1. Kd is the esti-
mated dissociation constant of the mimetic, [M] its concentration. Ku is the temperature-
dependent unfolding equilibrium constant (Ku = [denatured]/[native]) as measured by the
unfolding curve of mIL-10C149Y in the absence of mimetics. This model provides a relative
ranking of mimetic affinities but does not allow for a more detailed analysis with respect to
absolute binding enthalpy and entropy for which partially unfolded states need to be included.
In this case, the measured CD curves would be actually compatible with much higher mimetic
affinities, because a local stabilization of the mimetic binding epitope on mIL-10C149Y is not
counted as binding in the applied two state model but it is very likely to occur. For consistency,
we have not explored the higher affinity limit that would still be compatible with the data.
Instead, we report only the lower affinity range that complies with the assumptions, in order to
prevent bias for overestimated mimetic affinities. Due to the complicated underlying processes
of thermally induced complex dissociation and unfolding of both, mIL-10C149Y and designed
mimetics, we cannot relate the shift of the temperature mid point of unfolding (Tm) to more
specific thermodynamic parameters by a simple two state unfolding model. Absolute thermo-
dynamic parameters could only be obtained by isothermal titration calorimetry with the most
promising mimetics. This of course required the initial confirmation of the binding of the pre-
cursor molecules which was accomplished by CD and Fluorescence Spectroscopy. Fluorescence
emission at 360 nm was monitored simultaneously with the CD scan (the measuring beam
served as the excitation light) using a second monochromator and photomultiplier in 90°
geometry with respect to the CD absorption path. Thereby, temperature-dependent excitation
spectra of the tryptophan at position two in the synthetic IL-10R1 mimetics were additionally
obtained with the CD data acquisition. The thermally induced spectral differences between 334
K and 298 K were calculated for IL-10R1 mimetics in the absence and presence of mIL-
10C149Y.
Isothermal titration calorimetry (ITC)
ITC was performed with a Microcal VP-ITC calorimeter (GE Healthcare, Buckinghamshire, U.
K.) at 298 K. Aliquots (5–10 μL) of synthetic IL-10R1 mimeticsM5 andM6 (300–500 mM)
dissolved in the original dialysis buffer of the mIL-10C149Y preparation were injected into mIL-
10C149Y solutions (19–50 μM) until the molar ratio of mimetic: mIL-10C149Y exceeded 3 and
constant enthalpy changes were observed for repeated injections. The final constant heat sig-
nals were subtracted to correct for the solution enthalpy of the respective IL-10R1 mimetics.
The resulting integrated heat curve was analyzed with the associated software Origin 9 [74]
allowing a variable stoichiometry but restriction to a single Kd value (identical binding sites of
the dimeric protein).
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Supporting Information
S1 Fig. Cartoon representation of the crystal structure of the complex of human IL-10 (in
gray/violet) and IL-10R1 (in brown/yellow) (PDB ID 1J7V, 2.9 Å) and energetic details of
IL-10R1 residues involved in IL-10 binding. (A) Two molecules of IL-10R1 bind to two iden-
tical two-fold related surface areas of the protein composed of helix A, loop AB and helix F’ of
one IL-10 domain. (B) Close-up of the protein-receptor interface. The recognition site involves
27 protein residues (in violet) and 23 receptor residues (in yellow). Selected key binding resi-
dues of IL-10R1 (Tyr43, Arg76 and Arg96) and their binding counterparts in IL-10 are shown
in sticks, labeled and colored by atom type. The two red spheres represent interfacial crystallo-
graphic water molecules interacting with the key binding residues. Intermolecular H-bonds are
depicted by black dashed lines. Panels A and B were generated with PyMOL. (C) MM-PBSA
IL-10R1 residue binding energy contribution calculated fromMD simulation.
(PDF)
S2 Fig. Cartoon and surface representation of an IL-10 domain (in gray) in complex with
the manually docked selected structural motifs that best matched the defined 3D functional
descriptors (Table 1 in main text).Motifs 1ZYL, 2ACA (A), and 2ARZ (B) are represented by
a green ribbon, and their helical elongation is depicted in yellow. Those motif residues overlap-
ping with the selected IL-10R1 key binding residues (i.e. IL-10R1 residues Tyr43, Arg76 and
Arg96 in orange) are shown in sticks. The helix axis (represented by a black line) is oriented
longitudinally (A) or transversally (B) with respect to the helices A, B, F’ of IL-10.
Figure generated with PyMOL.
(PDF)
S3 Fig. Lactam bridge design strategy to stabilize the seeding template in an alpha-helical
scaffold. IL-10 and the scaffolds are represented as gray and green cartoons, respectively. Rele-
vant residues in each of the protein/scaffold complex are labeled and shown in sticks. The scaf-
folds Ac-[K1X2R3Y4D5]X6R7[K8X9X10X11D12]-NH2 (A), Ac-[K1X2R3Y4D5][K6R7X8X9D10]
X11X12-NH2 (B) and Ac-[K1X2R3Y4D5][K6R7K8X9D10]R11X12-NH2 (C) and their respective
180° rotation view are shown. Lactam bridges between the side chains of Lys and Asp are repre-
sented by brackets in sequence and in sticks in the structure models. Residue positions available
for substitutions in the scaffolds are highlighted with spheres at their Cα. Figure generated with
PyMOL.
(PDF)
S4 Fig. Interaction energy maps obtained for IL-10 with a series of GRID chemical probes.
(A) Interaction energies calculated for one IL-10 domain from the structure in complex with
the receptor-1 (in gray cartoon, PDB ID 1J7V (2.9 Å)) with an N3+ probe (sp3 amine NH3 cat-
ion). Two contour energy levels are shown at cutoffs -7.5 kcal/mol and -13.5 kcal/mol (cyan
and blue, respectively). The most favorable interactions with IL-10 involve residues from helix
A (Gln38) and loop AB (Asp41, Gln42) (highlighted in pink). Further favorable interactions in
the same region comprise residues of the loop AB (Asp44) and helix F’ (Ser141, Glu142,
Asp144) (highlighted in violet). (B) Interaction energies calculated for the unbound IL-10
(PDB ID 2ILK (1.6 Å)) with a water molecule or “solvent” chemical probe (contour energy
level at cutoff -7.5 kcal/mol shown in red) and for a carbon sp3 or “solvent exclusion” chemical
probe (contour energy level at cutoff -2.8 kcal/mol shown in green). Favorable interactions of
both, solvent and solvent exclusion probes, overlap with the mimetic binding region indicating
solvent exclusion. Three crystallographic waters found in the free IL-10 in this region are
shown as yellow spheres. Figure generated in VMD.
(PDF)
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S5 Fig. Molecular modeling of murine IL-10 mutant mIL-10C149Y. Top: sequence alignment
of murine and human proteins used for the homology modeling (sequence numbering as in
PDB ID 2ILK). Bottom: detail of one domain of the obtained 3D molecular model of mIL-
10C149Y (beige cartoon) superimposed with one domain of the human IL-10 used as template
(PDB ID 2ILK, gray cartoon) (RMSDCα: 0.8 Å). The protein residues involved in mimetic rec-
ognition are shown in sticks (pink for murine and violet for human. Figure generated with
PyMOL.
(PDF)
S6 Fig. Surface representation of a domain of IL-10 (in gray) in complex with mimetic M5
(in green, N-terminal functionalization in yellow) and RMSD along MD simulation. (A)
Hydrophobic interactions between mimetic residues K8, Y4, K-1 and protein residues D44, L46
and I145 are highlighted with labels. Structure taken from a snapshot of the MD simulation.
Figure generated with PyMOL. (B) Relative movement of mimetic M5 (given as backbone
RMSD) with respect to IL-10 along a 30 ns MD simulation.
(PDF)
S1 Table. List of motifs in the PDB database that match the 3D pattern syntax query R-
<2,6>-R-<4,5>-Y-.Matches corresponding to short regular secondary structures (maximum
10 residues long in the same chain) are highlighted in bold.
(PDF)
S2 Table. Summary of dynamic H-bond formation between IL-10 and IL-10R1 mimetics
M1-M6 along MD simulations.M1: Ac-[KW2R3Y4D][KR7K8VD]R11A-NH2, M2: X-
[KWR3Y4D][KR7K8VD]R11A-NH2 (X = 4-guanidinobutanoyl), M3: X-[KZR3Y4D]
[KR7K8VD]R11A-NH2 (X = 4-guanidinobutanoyl, Z = 5-Hydroxy-L-tryptophan), M4: Ac-R-
1[KWR3Y4D][KR7K8VD]R11A-NH2, M5: Ac-E-2K-1[KWR3Y4D][KR7K8VD]R11A-NH2, M6:
Ac-E-2R-1[KWR3Y4D][KR7K8VD]R11A-NH2.
#H-bonds observed along MD simulations of 10
ns for IL-10/M1 and 30 ns for IL-10/M2-M6 are shown in black. Additional H-bonds observed
during last 10 ns MD production for IL-10/M2-M6 are shown in gray. Interactions via struc-
tural bridging water. S: side chain. M: main chain. aNot observed during the last 10 ns MD pro-
duction.
(PDF)
S3 Table. Binding free energies for alanine mutants of M1, M4 and M6 calculated with the
MM-PBSA alanine scanning method.
(PDF)
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